Thealoz Duo

DEVICE3 trials

Sponsors

Laboratoires Thea, I-MED Pharma, Instituto Internacional de Medicina y Terapia (IIMET)

Conditions

Dry EyeDry Eye Syndrome (DES)Ocular Surface Disease

Unknown Phase

Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment

CompletedNCT04803240

Laboratoires TheaDry Eye

Start: 2019-04-01End: 2020-03-30Updated: 2021-03-17

I-DROP MGD Symptomatic Relief and Tear Film Stability

CompletedNCT05011708

I-MED PharmaDry Eye

Start: 2021-08-23End: 2022-01-12Updated: 2022-03-29

Twice-Daily Systane Complete Versus Four-Times-Daily Thealoz Duo for Dry Eye Disease

CompletedNCT07722650

Instituto Internacional de Medicina y Terapia (IIMET)Dry Eye Syndrome (DES), Ocular Surface Disease

Start: 2025-01-06End: 2025-06-30Updated: 2026-07-24

Related Papers

A Preservative-Free Combination of Sodium Hyaluronate and Trehalose Improves Dry Eye Signs and Symptoms and Increases Patient Satisfaction in Real-Life Settings: The TEARS Study.

2024-10-211 citations